Patent ID: 11905252
Assignee: INFLAZOME LIMITED
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 9:
10. The compound or pharmaceutically acceptable salt or solvate thereof, as claimed in claim 9, wherein R2 has a formula selected from:, wherein:
A1 and A2 are each independently selected from a straight chain alkylene group, wherein one or two carbon atoms in the backbone of the alkylene group may optionally be replaced by one or two heteroatoms independently selected from nitrogen and oxygen, wherein the alkylene group may optionally be substituted with one or more halo,-OH, —CN, —O(C1-C4 alkyl) or —O(C1-C4 haloalkyl) groups, and wherein any ring containing A1 or A2 is a 5- or 6-membered ring;
each R4 is independently selected from a C1-C6 alkyl or C3-C6 cycloalkyl group, wherein the C1-C6 alkyl or C3-C6 cycloalkyl group may optionally be substituted with one or more halo, —OH, —CN, —O(C1-C4 alkyl) or —O(C1-C4 haloalkyl) groups; and
each R5 is independently selected from hydrogen or a halo group.